Wuxi Jinyi Fuxin Biopharmaceutical Venture Capital Partnership

Wuxi Jinyi Fuxin Biopharmaceutical Venture Capital Partnership is a state-owned venture capital firm based in Wuxi, Jiangsu Province, China. The firm specializes in investing in the biopharmaceutical sector, including areas such as biomedicine, life sciences, medical devices, and contract research organizations (CRO). It aims to support the development of innovative technologies and address major unmet clinical needs in the healthcare industry.

The firm's investment strategy encompasses various stages of company development, from seed and early-stage investments to growth and late-stage funding. By providing capital and strategic support, Wuxi Jinyi Fuxin seeks to accelerate the commercialization of groundbreaking medical solutions and contribute to the advancement of the biopharmaceutical industry in China.

Through its investments, the firm plays a pivotal role in strengthening the biopharmaceutical industry chain in Wuxi and promoting the integration of scientific and technological innovation with industrial development. This approach aligns with Wuxi's goal of becoming a significant national base for biopharmaceuticals, with the industry scale projected to exceed 200 billion yuan by 2023.